The federal shift in cannabis policy is opening the door to broader tax deductions, but the transition is creating a new set of compliance challenges for businesses operating in the industry.
For years, companies dealing with cannabis had limited options under Section 280E of the Internal Revenue Code. Because that provision barred most business deductions, operators generally tried to place eligible expenses within inventory costs, allowing them to recover those amounts through cost of goods sold.
That approach was restrictive. Inventory costs could reduce taxable income only when products were sold, while ordinary business expenses, including administrative and corporate costs, generally remained unavailable.
The situation changed after medical marijuana was moved to Schedule 3 in April 2026. The IRS has said the new classification applies to the full tax year containing the effective date of the federal order. As a result, medical marijuana businesses can generally move toward ordinary tax deductions rather than relying solely on inventory accounting.
However, the transition is not automatic.
Businesses that have recreational and medical marijuana sales face particular difficulties. Until recreational marijuana receives the same federal treatment, companies must reasonably divide shared expenses such as overheads, wages, and utilities between the two operations. The correct treatment may also depend on a company’s fiscal year.
Another concern involves expenses previously included in inventory. Simply transferring those amounts into current deductions could create inconsistencies that attract IRS scrutiny. Tax authorities can compare current filings with earlier returns and may question why an expense previously classified one way is now receiving different treatment.
Changes involving when income is recognized or deductions are claimed can also qualify as accounting-method changes. In some circumstances, taxpayers may need to submit Form 3115 to disclose the change or obtain approval. Because the filing carries a declaration under penalty of perjury, inaccurate reporting can create serious consequences.
Rescheduling also changes how inventory costs are calculated. Expenses that were previously treated differently under the restrictions of Section 280E may now have to be capitalized under broader uniform capitalization rules. Purchasing, handling, storage, and certain shared administrative costs can all become relevant.
The tax consequences extend beyond future filings. Operators should examine earlier returns, inventory records, and expense allocations to determine whether past treatment remains defensible. Differences should be traced to changes in circumstances, legal requirements, or accounting methods.
Some businesses may also consider protective refund claims for earlier years while litigation continues over whether marijuana might have fallen outside Section 280E before formal rescheduling.
The central lesson is caution. A transition that promises significant tax relief can also expose companies to additional liabilities, interest, penalties, and, in serious cases, legal consequences. Reviewing historical records and planning the accounting changes before filing new returns may prove far less costly than correcting errors after an IRS examination.
Leading marijuana businesses like Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) are probably having serious discussions with their tax and legal advisors in order to avoid making mistakes as they seek to benefit from the changes that come with medical cannabis rescheduling.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN